SeqLL Inc. (SQL) |
|
1.53 -0.01 (-0.65%)
|
02-08 10:00 |
|
Open: |
1.31 |
Pre. Close: |
1.54 |
|
High:
|
1.7 |
Low:
|
1.3 |
|
Volume:
|
4,773,479 |
Market Cap:
|
18(M) |
|
|
|
Technical analysis |
as of: 2023-02-08 9:51:40 AM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.8 One year: 3.27 |
| Support: |
Support1: 1.09 Support2: 0.28 |
| Resistance: |
Resistance1: 2.4 Resistance2: 2.8 |
| Pivot: |
0.6  |
| Moving Average: |
MA(5): 0.9 MA(20): 0.54
MA(100): 0.52 MA(250): 0.8 |
| MACD: |
MACD(12,26): 0.1 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 65.1  %D(3): 78.4 |
| RSI: |
RSI(14): 81 |
| 52-week: |
High: 2.4 Low: 0.23 |
| Average Vol(K): |
3-Month: 1,856 (K) 10-Days: 10,696 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SQL ] has closed above the upper band by 6.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 522.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.4 - 2.41 |
2.41 - 2.42 |
|
Low:
|
1.39 - 1.4 |
1.4 - 1.41 |
|
Close:
|
1.53 - 1.54 |
1.54 - 1.55 |
|
Company Description |
|
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts. |
Headline News |
Wed, 08 Feb 2023
SeqLL Inc (SQL) Down 20.78% in Premarket Trading - InvestorsObserver
Tue, 07 Feb 2023
SQL Technologies (SKYX) to acquire Belami - StreetInsider.com
Mon, 06 Feb 2023
How the latest SQL injection attacks threaten web application firewalls - SC Media
Mon, 06 Feb 2023
SQL and Python Interview Questions for Data Analysts - KDnuggets
Fri, 03 Feb 2023
SQL Data Types | DatabaseJounral.com - Database Journal
Tue, 31 Jan 2023
Let SQL Do All the Work: User Defined Functions - The New Stack
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
0 (M) |
| Shares Float |
12 (M) |
|
% Held by Insiders
|
4.58e+006 (%) |
|
% Held by Institutions
|
36.7 (%) |
|
Shares Short
|
11 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.66e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-1 |
|
Return on Assets (ttm)
|
665.4 |
|
Return on Equity (ttm)
|
-32.1 |
|
Qtrly Rev. Growth
|
164530 |
|
Gross Profit (p.s.)
|
0.01 |
|
Sales Per Share
|
0.01 |
|
EBITDA (p.s.)
|
-0.14 |
|
Qtrly Earnings Growth
|
-0.5 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-4 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
77.56 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
2220 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
